Daymark Health, a company transforming the cancer care experience for patients, providers, and health plans, publicly launched with an $11.5 million seed funding round co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Ventures. And the company started operations this year in partnership with a leading payer in the Northeast to provide evidence-based, supportive cancer care to over 2,500 cancer patients.
Around two million people are diagnosed with cancer in the United States annually, and each one will spend over 8,500 hours per year outside the four walls of their oncology clinic, meaning patients are often left to manage questions, symptoms, and urgent needs on their own.
Daymark Health was created to address the clinical, mental health, and social needs that matter most to patients with cancer, delivered through a comprehensive, proven cancer care platform and a value-based care model that takes on total cost of care risk contracts for health plans. And through partnerships with payers, Daymark’s community-based team of nurse practitioners, nurses, social workers, and Health Partners works in tandem with a patient’s own oncologists and primary care providers to optimize the delivery of care, both virtually and in the home.
Daymark Health’s $11.5 million funding from the industry’s premier healthcare and oncology funds, Maverick Ventures, Yosemite, and Oncology Ventures, will enable the company to expand its clinical team, accelerate the development and scale of its platform, and launch new health plan partnerships across the country.
Along with Dr. Bekelman, Daymark has assembled an exceptional oncology leadership team. Roy Beveridge, former Chief Medical Officer of Humana and U.S. Oncology, will join Daymark as Executive Board Chair, and Ezekiel Emanuel, architect of the Affordable Care Act, will join Daymark as Clinical Advisory Board Chair.
Daymark was launched out of Healthcare Foundry as a built-for-purpose company. Robert Pahlavan and Jonathan Rhodes were co-founders and led thesis development. Both have assumed roles within Daymark to support the company’s growth and operations.
KEY QUOTES:
“Despite the advances in cancer treatment made over the past 50 years, patients still face a fragmented health system that gets in the way of comprehensive, personalized cancer care. We are delighted to launch our care platform to patients across the country and set a new standard of cancer care, one that will redefine what’s possible in oncology.”
- Dr. Justin Bekelman, CEO and Co-Founder of Daymark Health and renowned oncologist, innovator, and former leader of Penn Medicine’s Center for Cancer Care Innovation at the Abramson Cancer Center
“Daymark Health represents the next evolution in specialty value-based care companies – optimizing care for the special and complex population of patients with cancer. We are thrilled to partner with Dr. Bekelman and the team at Daymark to bring this proven care model to fruition.”
- Ambar Bhattacharyya, Managing Director at Maverick Ventures
“There is a glaring need to reform cancer care delivery to reflect the realities of the patient experience. Daymark’s platform for navigating care does just that — aligning patients, providers, and payers for personalized care and improved outcomes.”
- Matt Bettonville, Investor at Yosemite
